CYCN
Cyclerion Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.25
−14.31%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$6.00
- Revenue estimate
- $900.0K
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- -$0.41
- EPS estimate
- -$7.10
- Revenue actual
- —
- Revenue estimate
- $1.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +82.6%
- Revenue beats (12Q)
- 2
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026